The serotonin system and dopamine system are two important neuromodulators in the body. They both modify the activity of other circuits in the body and can lead to different experiences. Drugs like LSD and psilocybin primarily target the serotonin system and can lead to profound model challenges.
Dr. Matthew Johnson
Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. They discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and LSD.
Check out the latest posts